National Medical Marijuana Legalization May Be Introduced in 2020, Bruce Linton Says

The video discusses the transition from Canopy Growth to working with US cannabis companies, focusing on adapting to the US market amid uncertain federal legalization. It highlights the importance of scientific approaches and data in monitoring vape safety and regulatory compliance. The speaker emphasizes intellectual property and strategic business decisions, including the role of the FDA in vaping regulations. Leadership strategies and their impact on market performance are also explored.

What challenges does the speaker identify regarding FDA regulations on vaping?

How does the speaker suggest ensuring the safety of CBD products?

What strategies does the speaker propose for creating value in a cannabis company?